AR and myocardial ischemia: The clinical potential of AR synthetic ligands in the treatment of IHD is a subject of considerable interest, given the multifaceted role of adenosine in cardiovascular physiology and pathology [30,34,80,119,120,121,122,123,124,125,126,236,237].